- Home
- RVPH vs STG Comparison
RVPH vs STG Comparison
Compare RVPH & STG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- STG
- Stock Information
- Founded
- RVPH 2006
- STG 2003
- Country
- RVPH United States
- STG China
- Employees
- RVPH N/A
- STG N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- STG Other Consumer Services
- Sector
- RVPH Health Care
- STG Real Estate
- Exchange
- RVPH Nasdaq
- STG Nasdaq
- Market Cap
- RVPH 88.0M
- STG 84.9M
- IPO Year
- RVPH N/A
- STG 2018
- Fundamental
- Price
- RVPH $1.04
- STG $5.59
- Analyst Decision
- RVPH Strong Buy
- STG
- Analyst Count
- RVPH 5
- STG 0
- Target Price
- RVPH $11.40
- STG N/A
- AVG Volume (30 Days)
- RVPH 1.1M
- STG 4.1K
- Earning Date
- RVPH 05-13-2025
- STG 03-21-2025
- Dividend Yield
- RVPH N/A
- STG N/A
- EPS Growth
- RVPH N/A
- STG N/A
- EPS
- RVPH N/A
- STG 4.57
- Revenue
- RVPH N/A
- STG $292,030,936.00
- Revenue This Year
- RVPH N/A
- STG N/A
- Revenue Next Year
- RVPH N/A
- STG N/A
- P/E Ratio
- RVPH N/A
- STG $1.22
- Revenue Growth
- RVPH N/A
- STG N/A
- 52 Week Low
- RVPH $0.60
- STG $4.25
- 52 Week High
- RVPH $4.28
- STG $11.06
- Technical
- Relative Strength Index (RSI)
- RVPH 25.55
- STG 38.54
- Support Level
- RVPH $1.12
- STG $4.70
- Resistance Level
- RVPH $1.23
- STG $6.76
- Average True Range (ATR)
- RVPH 0.13
- STG 0.36
- MACD
- RVPH -0.03
- STG -0.12
- Stochastic Oscillator
- RVPH 0.00
- STG 43.20
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.